Pancreatic Cancer Research

ResearcherEssen University HospitalActive in the last 2 years

Kim Magaly Pabst

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9234-0795; OpenAlex author ID A5053681162. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

  1. The Value of FAPI PET/CT in Cholangiocarcinoma and Pancreatic Cancer: An Update. Co-author DOI 10.1053/j.semnuclmed.2025.06.011↗
  2. 68Ga-Labeled Fibroblast Activation Protein Inhibitor (68Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the 68Ga-FAPI PET Observational Trial. Co-author DOI 10.2967/jnumed.122.264827↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wolfgang P. Fendler · 2 shared papers, 2023–2025 · strength 0.51
  2. Ken Herrmann · 2 shared papers, 2023–2025 · strength 0.51
  3. Céline Lugnier · 1 shared paper, 2023 · strength 0.15
  4. Waldemar H. Uhl · 1 shared paper, 2023 · strength 0.15
  5. Lukas Kessler · 1 shared paper, 2023 · strength 0.15
  6. David P. Witte · 1 shared paper, 2023 · strength 0.15
  7. Jens Thomas Siveke · 1 shared paper, 2023 · strength 0.15
  8. Anke Reinacher‐Schick · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.